Entrada Therapeutics, Inc.

TRDA · Nasdaq · SIC 2834: Pharmaceutical Preparations
76
SEC Filings

Business Summary

PART I Overview We are a clinical-stage biopharmaceutical company aiming to transform the lives of patients by e stablishing a new class of medicines that engage intracellular targets that have long been considered inaccessible . Through proprietary, versatile and modular approaches, we are advancing a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases, among others. In 2026, we expect to progress our ENTR-601-44 and ENTR...

Next Earnings

Q2 FY2026 — expected 2026-08-09

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionTRDAdiscussed_in_filing Cybersecurity
topic_mentionTRDAdiscussed_in_filing Trusted Computing
topic_mentionTRDAdiscussed_in_filing Blockchain & Crypto
topic_mentionTRDAdiscussed_in_filing Capital Expenditure
topic_mentionTRDAdiscussed_in_filing Regulation
topic_mentionTRDAdiscussed_in_filing Automotive
topic_mentionTRDAdiscussed_in_filing Healthcare & Bio
topic_mentionTRDAdiscussed_in_filing Platform & Ecosystem
topic_mentionTRDAdiscussed_in_filing Sovereign & Government
topic_mentionTRDAdiscussed_in_filing Cybersecurity
topic_mentionTRDAdiscussed_in_filing Trusted Computing
topic_mentionTRDAdiscussed_in_filing Blockchain & Crypto
topic_mentionTRDAdiscussed_in_filing Capital Expenditure
topic_mentionTRDAdiscussed_in_filing Regulation
topic_mentionTRDAdiscussed_in_filing Automotive
topic_mentionTRDAdiscussed_in_filing Healthcare & Bio
topic_mentionTRDAdiscussed_in_filing Platform & Ecosystem
topic_mentionTRDAdiscussed_in_filing Sovereign & Government
topic_mentionTRDAdiscussed_in_filing Cybersecurity
topic_mentionTRDAdiscussed_in_filing Trusted Computing

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001689375-26-000011EDGAR111K words
2025-02-272024-12-310001689375-25-000011EDGAR—
2024-03-132023-12-310001689375-24-000016EDGAR—
2023-03-062022-12-310001689375-23-000019EDGAR—
2022-03-152021-12-310001558370-22-003614EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001689375-25-000050EDGAR75K words
2025-08-062025-06-300001689375-25-000043EDGAR—
2025-05-082025-03-310001689375-25-000024EDGAR—
2024-11-052024-09-300001689375-24-000063EDGAR—
2024-08-132024-06-300001689375-24-000047EDGAR—
2024-05-072024-03-310001689375-24-000027EDGAR—
2023-11-072023-09-300001689375-23-000074EDGAR—
2023-08-082023-06-300001689375-23-000055EDGAR—
2023-05-102023-03-310001689375-23-000039EDGAR—
2022-11-072022-09-300001689375-22-000045EDGAR—
2022-08-112022-06-300001689375-22-000013EDGAR—
2022-05-122022-03-310001689375-22-000004EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-260001689375-26-000009EDGAR3K words
2026-01-080001689375-26-000003EDGAR—
2025-11-060001689375-25-000049EDGAR—
2025-08-060001689375-25-000041EDGAR—
2025-06-110001104659-25-058536EDGAR—
2025-06-030001689375-25-000027EDGAR—
2025-05-080001689375-25-000022EDGAR—
2025-04-290001104659-25-041204EDGAR—
2025-03-240001689375-25-000018EDGAR—
2025-02-270001689375-25-000009EDGAR—

76 total filings indexed. 49 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001689375
TickerTRDA
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 304a645b2f3f969dff11a62e231c63b85647a0cbe94a8e0f4a34ad64ffaaf27c
parent: 9c83c7b21f84a4873bbd517d703680cd9c0178e0c932f170ff4fef946a10c132
content hash: 2b982cf7359c8fb8524e85fdbda059b6778f33d922bcf9be4f087f1ed15891ec
signed: 2026-04-13T04:47:52.093Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf